News

Krystal reports on venture capital and startups ... CoreWeave's shares closed flat after opening nearly 3% below their offer price in its Nasdaq debut on Friday, giving the Nvidia-backed AI ...
A Chicago police officer shot and killed a fellow officer during a tactical operation Thursday night, police said.
Krystal Rivera, a 36-year-old officer with the Chicago Police Department, Illinois, was shot and killed in the line of duty ...
The Chicago police officer killed in Chatham was identified as 36-year-old Krystal Rivera, a mother and a four-year veteran ...
The most recent analyst rating on (KRYS) stock is a Buy with a $208.00 price target. To see the full list of analyst forecasts on Krystal Biotech stock, see the KRYS Stock Forecast page.
In the assessment of 12-month price targets, analysts unveil insights for Krystal Biotech, presenting an average target of $218.17, a high estimate of $245.00, and a low estimate of $155.00.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
KRYSTAL KING: Thanks for having us ... We can't get rubber ducks in anymore for a price point that makes any kind of sense for anybody. SIMON: But this is - I mean, this is a big move.
Based on the one-year price targets offered by 10 analysts, the average target price for Krystal Biotech Inc (NASDAQ:KRYS) is $217.20, with a high estimate of $245.00 and a low estimate of $195.00.